3/5
08:30 pm
tngx
Tango Therapeutics (TNGX) Hits All-Time High as Analyst Turns Bullish [Yahoo! Finance]
Neutral
Report
Tango Therapeutics (TNGX) Hits All-Time High as Analyst Turns Bullish [Yahoo! Finance]
3/5
08:07 pm
tngx
Tango Therapeutics (TNGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Neutral
Report
Tango Therapeutics (TNGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/5
07:29 am
tngx
Tango Therapeutics GAAP EPS of -$0.29 beats by $0.03, revenue of $0M misses by $0.5M [Seeking Alpha]
High
Report
Tango Therapeutics GAAP EPS of -$0.29 beats by $0.03, revenue of $0M misses by $0.5M [Seeking Alpha]
3/5
07:00 am
tngx
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
High
Report
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
3/4
06:48 pm
tngx
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing [Yahoo! Finance]
High
Report
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing [Yahoo! Finance]
2/23
09:00 am
tngx
Tango Therapeutics (NASDAQ:TNGX) is now covered by analysts at Mizuho. They set an "outperform" rating and a $19.00 price target on the stock.
Medium
Report
Tango Therapeutics (NASDAQ:TNGX) is now covered by analysts at Mizuho. They set an "outperform" rating and a $19.00 price target on the stock.
2/18
07:00 am
tngx
Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences
Medium
Report
Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences
2/15
02:21 pm
tngx
Tango Therapeutics CEO Teases Pivotal Vopimetostat Trial, RAS Combo Data at Guggenheim Chat [Yahoo! Finance]
Low
Report
Tango Therapeutics CEO Teases Pivotal Vopimetostat Trial, RAS Combo Data at Guggenheim Chat [Yahoo! Finance]
2/6
09:47 am
tngx
Tango Therapeutics (NASDAQ:TNGX) had its price target raised by analysts at Guggenheim from $12.00 to $18.00. They now have a "buy" rating on the stock.
Medium
Report
Tango Therapeutics (NASDAQ:TNGX) had its price target raised by analysts at Guggenheim from $12.00 to $18.00. They now have a "buy" rating on the stock.
2/3
07:00 am
tngx
Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Medium
Report
Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
1/28
05:49 pm
tngx
DUB Inhibitors Market to Witness Strong Expansion Across 7MM by 2040 Driven by the Launch of Novel Therapeutics | DelveInsight [Yahoo! Finance]
Medium
Report
DUB Inhibitors Market to Witness Strong Expansion Across 7MM by 2040 Driven by the Launch of Novel Therapeutics | DelveInsight [Yahoo! Finance]
1/9
01:46 pm
tngx
Does Tango Therapeutics' (TNGX) CEO Transition Clarify or Complicate Its Precision Oncology Roadmap? [Yahoo! Finance]
Low
Report
Does Tango Therapeutics' (TNGX) CEO Transition Clarify or Complicate Its Precision Oncology Roadmap? [Yahoo! Finance]
1/8
07:05 pm
tngx
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor [Yahoo! Finance]
Medium
Report
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor [Yahoo! Finance]
1/8
09:05 am
tngx
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor
Medium
Report
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor
1/5
07:19 am
tngx
Tango Therapeutics Appoints Sung Lee to Board of Directors [Yahoo! Finance]
Medium
Report
Tango Therapeutics Appoints Sung Lee to Board of Directors [Yahoo! Finance]
1/5
07:00 am
tngx
Tango Therapeutics Appoints Sung Lee to Board of Directors
Medium
Report
Tango Therapeutics Appoints Sung Lee to Board of Directors
12/17
07:00 am
tngx
Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference
12/14
03:16 pm
tngx
Is Tango Therapeutics (TNGX) Overvalued After a 200% One-Year Surge? A Fresh Look at Its Pricing [Yahoo! Finance]
Low
Report
Is Tango Therapeutics (TNGX) Overvalued After a 200% One-Year Surge? A Fresh Look at Its Pricing [Yahoo! Finance]
12/13
01:10 am
tngx
Tango Therapeutics (NASDAQ:TNGX) was upgraded by analysts at
Wall Street
Low
Report
Tango Therapeutics (NASDAQ:TNGX) was upgraded by analysts at
Wall Street